Literature DB >> 19509131

Photodynamic therapy: a light in the darkness?

Alexander Lin1, Stephen M Hahn.   

Abstract

Photodynamic therapy (PDT) is used to treat localized premalignant or early malignant disease. This study reports the enhanced, systemic antitumor immune response from PDT, suggesting that it may have a potential role as a therapy to address both local and disseminated disease.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19509131     DOI： 10.1158/1078-0432.CCR-09-0964

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  4 in total

1.  HMME-based PDT restores expression and function of transporter associated with antigen processing 1 (TAP1) and surface presentation of MHC class I antigen in human glioma.

Authors:  Shan-Yi Zhang; Jun-Liang Li; Xin-Ke Xu; Mei-Guang Zheng; Cheng-Cai Wen; Fang-Cheng Li
Journal:  J Neurooncol       Date:  2011-04-26       Impact factor: 4.130

2.  Basal cell carcinoma of the head and neck.

Authors:  Masahiro Nakayama; Keiji Tabuchi; Yasuhiro Nakamura; Akira Hara
Journal:  J Skin Cancer       Date:  2010-12-15

3.  Photodynamic-therapy Activates Immune Response by disrupting Immunity Homeostasis of Tumor Cells, which Generates Vaccine for Cancer Therapy.

Authors:  Yuanhong Zheng; Guifang Yin; Vanminh Le; Anle Zhang; Siyu Chen; Xin Liang; Jianwen Liu
Journal:  Int J Biol Sci       Date:  2016-01-01       Impact factor: 6.580

4.  Magnetic and pH dual-responsive mesoporous silica nanocomposites for effective and low-toxic photodynamic therapy.

Authors:  Jieqiong Zhan; Zhiqiang Ma; Dan Wang; Xinfang Li; Xiangui Li; Lijing Le; Anfeng Kang; Pengwei Hu; Lan She; Feng Yang
Journal:  Int J Nanomedicine       Date:  2017-04-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.